B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.

Reddy, Venkat; Jayne, David; Close, David; Isenberg, David

View / Open Files

Published version (PDF, 758Kb)

Authors

Reddy, Venkat

Jayne, David

Close, David

Isenberg, David

Publication Date

2013-01

Journal Title

Arthritis research & therapy

ISSN

1478-6354

Volume

15 Suppl 1

Language

eng

Type

Article

This Version

VoR

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Reddy, V., Jayne, D., Close, D., & Isenberg, D. (2013). B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.. Arthritis research & therapy, 15 Suppl 1 S2. https://doi.org/10.1186/ar3910

Keywords

B-Lymphocytes, Humans, Lupus Erythematosus, Systemic, Immunologic Factors, Treatment Outcome, Dose-Response Relationship, Drug, Randomized Controlled Trials as Topic, Antibodies, Monoclonal, Murine-Derived, Antibodies, Monoclonal, Humanized

Identifiers

External DOI: https://doi.org/10.1186/ar3910

This record's URL: https://www.repository.cam.ac.uk/handle/1810/313307

Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/

Except where otherwise noted, this item's licence is described as Attribution 4.0 International